Background: Panel-based targeted exome sequencing was used to analyze the genetic and clinical findings of targeted genes in a cohort of northeast Chinese with retinitis pigmentosa.

Methods: A total of 87 subjects, comprising 23 probands and their family members (total patients: 32) with confirmed retinitis pigmentosa were recruited in the study. Panel-based targeted exome sequencing was used to sequence the patients and family members, all subjects with retinitis pigmentosa underwent a complete ophthalmologic examination.

Results: Of the 23 probands, the clinical manifestations include night blindness, narrowing of vision, secondary cataracts, choroidal atrophy, color blindness, and high myopia, the average age of onset of night blindness is 12.9 ± 14 (range, 0-65; median, 8). Posterior subcapsular opacities is the most common forms of secondary cataracts (nine cases, 39.1%), and peripheral choroidal atrophy is the most common form of secondary choroidal atrophy (12 cases, 52.2%). Of these probands with complication peripheral choroidal atrophy, there were eight probands (66.7%, 8/12) caused by the pathogenic variation in USH2A gene. A total of 17 genes and 45 variants were detected in 23 probands. Among these genes, the commonest genes were USH2A (40%; 18/45), RP1 (15.6%; 7/45), and EYS (8.9%; 4/45), and the top three genes account for 56.5% (13/23) of diagnostic probands. Among these variants, comprising 22 (48.9%) pathogenic variants, 14 (31%) likely pathogenic variants, and nine (20%) uncertain clinical significance variants, and 22 variants was discovered first time. Most of the mutations associated with RP were missense (53.3%, 24/45), and the remaining mutation types include frameshift (35.6%, 16/45), nonsense (6.7%, 3/45), and spliceSite (4.4%, 2/45). Among the probands with mutations detected, compound heterozygous forms was detected in 13 (56.5%, 13/23) probands, and digenic inheritance (DI) forms was detected in five (21.7%, 5/23) probands.

Conclusion: Panel-based targeted exome sequencing revealed 23 novel mutations, recognized different combinations forms of variants, and extended the mutational spectrum of retinitis pigmentosa and depicted common variants in northeast China.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196472PMC
http://dx.doi.org/10.1002/mgg3.1184DOI Listing

Publication Analysis

Top Keywords

panel-based targeted
16
targeted exome
16
exome sequencing
16
retinitis pigmentosa
16
choroidal atrophy
16
genetic clinical
8
clinical findings
8
northeast chinese
8
probands
8
family members
8

Similar Publications

Hand, foot, and mouth disease (HFMD) is a serious pediatric infectious disease that causes immeasurable physical and mental health burdens. Currently, there is a lack of information on the mechanisms of HFMD severity and early diagnosis. We performed metabolomic profiling of sera from 84 Enterovirus A71 (EV-A71) infections and 45 control individuals.

View Article and Find Full Text PDF
Article Synopsis
  • * They used a retrospective design to match patients receiving the multi-gene test to those undergoing single-gene testing, focusing on survival outcomes and costs from a healthcare payer's perspective.
  • * Results showed that multi-gene panel testing had longer turnaround times and slightly increased costs, but it also resulted in marginally better survival rates; however, the overall net monetary benefit was inconclusive, with varying cost-effectiveness results across multiple scenarios.
View Article and Find Full Text PDF

Background: The complexity of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH) may require the simultaneous analysis of variant types of protein biomarkers to describe it more accurately. In this study, we analyzed for the first time the alterations of cerebrospinal fluid (CSF) proteins in patients with aSAH by multi-targeted Olink proteomics, aiming to reveal the pathophysiology of DCI and provide insights into the diagnosis and treatment of aSAH.

Methods: Six aSAH patients and six control patients were selected, and CSF samples were analyzed by Olink Proteomics (including 96-neurology panel and 96-inflammation panel) based on Proximity Extension Assay (PEA).

View Article and Find Full Text PDF

Implementation of pharmacogenomics: Experience at Ochsner Health.

Am J Health Syst Pharm

October 2024

Specialty and Infusion Pharmacies, University of Illinois Health, Chicago, IL, and Department of Pharmacy Practice, University of Illinois Chicago, Chicago, IL, USA.

Purpose: Pharmacogenomics is the study of how individual responses to medication are influenced by genetics. As medication experts, pharmacists are uniquely suited to practicing this application of precision medicine. Fundamental operational aspects of developing a pharmacy clinical pharmacogenomics practice are described, and the specific experience of a multisite health system in developing a pharmacogenomics service is discussed.

View Article and Find Full Text PDF
Article Synopsis
  • Neurodevelopmental disorders (NDDs) pose significant diagnostic challenges in pediatric genetics, necessitating advanced tools like whole exome sequencing (WES) to identify genetic variants in affected children.
  • A study of 176 Spanish-speaking pediatric patients found that the overall diagnostic yield for WES was 17.1%, with varying yields based on specific disorders: 20.8% for intellectual disability (ID), 12.7% for ASD + ID, and 3.2% for autism spectrum disorder (ASD) alone.
  • The study supports a sequential diagnostic approach using WES followed by parental testing to enhance accuracy and cost-effectiveness, especially for children with syndromic ID.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!